Augmented pulmonary IL-4 and IL-13 receptor subunit expression in idiopathic interstitial pneumonia

被引:43
|
作者
Jakubzick, C
Choi, ES
Kunkel, SL
Evanoff, H
Martinez, FJ
Puri, RK
Flaherty, KR
Toews, GB
Colby, TV
Kazerooni, EA
Gross, BH
Travis, WD
Hogaboam, CM
机构
[1] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Sch Med, Dept Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48104 USA
[3] Univ Michigan, Sch Med, Dept Radiol, Ann Arbor, MI 48104 USA
[4] US FDA, Lab Mol Tumor Biol, Div Cellular & Gene Therapies, Ctr Biol Evaluat & Res, Rockville, MD 20852 USA
[5] Mayo Clin, Scottsdale, AZ 85259 USA
[6] Armed Forces Inst Pathol, Washington, DC 20306 USA
关键词
D O I
10.1136/jcp.2003.012799
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Background: Some idiopathic interstitial pneumonias (IIPs) are characterised by fibroproliferation and deposition of extracellular matrix. Because efficacious treatment options are limited, research has been directed towards understanding the cytokine networks that may affect fibroblast activation and, hence, the progression of certain IIPs. Aims: To examine the expression of interleukin 4 (IL-4), IL-13, and their corresponding receptor subunits in the various forms of IIP and normal patient groups. Methods: Molecular and immunohistochemical analysis of IL-4, interferon gamma (IFNgamma), IL-13, IL-4 receptor (IL-R), and IL-13 receptor subunits in surgical lung biopsies (SLBs) from 39 patients (21 usual interstitial pneumonia (UIP), six non-specific interstitial pneumonia (NSIP), eight respiratory bronchiolitic interstitial lung disease (RBILD), and five normal controls). Results: Molecular analysis demonstrated that IL-13Ralpha2, IL-13Ralpha1, and IL-4Ralpha were present in a greater proportion of upper and lower lobe biopsies from patients with UIP than patients with NSIP and RBILD. Immunohistochemical analysis of patients with UIP, NSIP, and RBILD revealed interstitial staining for all three receptor subunits, whereas such staining was only seen in mononuclear cells present in normal SLBs. Fibroblastic foci in patients with UIP strongly stained for IL-4Ralpha and IL-13Ralpha2. Localised expression of IL-4Ralpha was also seen in SLBs from patients with NSIP but not in other groups. Conclusion: Some histological subtypes of IIP are associated with increased pulmonary expression of receptor subunits responsive to IL-4 and IL-13. These findings may be of particular importance in understanding the pathogenesis of IIP and, more importantly, may provide important novel therapeutic targets.
引用
收藏
页码:477 / 486
页数:10
相关论文
共 50 条
  • [1] Dexamethasone Modulates IL-13 and IL-4 Receptor Subunit Expression in Airway Fibroblasts in Asthma.
    Ingram, J. L.
    Huggins, M. J.
    Church, T. D.
    Francisco, D.
    Beaver, D. M.
    Kraft, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [2] The evolution of IL-4 and IL-13 and their receptor subunits
    Wang, Tiehui
    Secombes, Christopher J.
    CYTOKINE, 2015, 75 (01) : 8 - 13
  • [3] Distinct roles for IL-13 and IL-4 via IL-13 receptor α1 and the type II IL-4 receptor in asthma pathogenesis
    Munitz, A.
    Brandt, E. B.
    Mingler, M.
    Finkelmant, F. D.
    Rothenberg, M. E.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (20) : 7240 - 7245
  • [4] Distinct signal requirement for IL-4 and IL-13 expression
    Keen, JC
    Natarajan, S
    Burke, T
    Guo, J
    Cianferoni, A
    Schmidt, J
    Casolaro, V
    Wills-Karp, M
    Georas, SN
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 107 (02) : S148 - S148
  • [5] THE IL-2 RECEPTOR GAMMA(C) CHAIN DOES NOT FUNCTION AS A SUBUNIT SHARED BY THE IL-4 AND IL-13 RECEPTORS - IMPLICATION FOR THE STRUCTURE OF THE IL-4 RECEPTOR
    HE, YW
    MALEK, TR
    JOURNAL OF IMMUNOLOGY, 1995, 155 (01): : 9 - 12
  • [6] IL-13 receptor α 2:: A regulator of IL-13 and IL-4 signal transduction in primary human fibroblasts
    Andrews, Allison-Lynn
    Nasir, Tosia
    Bucchieri, Fabio
    Holloway, John W.
    Holgate, Stephen T.
    Davies, Donna E.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 118 (04) : 858 - 865
  • [7] IL-4 receptor α polymorphisms are predictors of a pharmacogenetic response to a novel IL-4/IL-13 antagonist
    Slager, Rebecca E.
    Hawkins, Gregory A.
    Ampleford, Elizabeth J.
    Bowden, Alexandra
    Stevens, Lauren E.
    Morton, Matthew T.
    Tomkinson, Adrian
    Wenzel, Sally E.
    Longphre, Malinda
    Bleecker, Eugene R.
    Meyers, Deborah A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 126 (04) : 875 - 878
  • [8] Structure, binding, and antagonists in the IL-4/IL-13 receptor system
    Mueller, TD
    Zhang, JL
    Sebald, W
    Duschl, A
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2002, 1592 (03): : 237 - 250
  • [9] Structural similarity of IL-13 and IL-4
    Tang, JCT
    Cannon-Carlson, S
    Varnerin, J
    Tsarbopoulos, A
    Wylie, D
    FASEB JOURNAL, 1997, 11 (09): : A1361 - A1361
  • [10] IL-4 receptor α is an important modulator of IL-4 and IL-13 receptor binding:: Implications for the development of therapeutic targets
    Andrews, Allison-Lynn
    Holloway, John W.
    Holgate, Stephen T.
    Davies, Donna E.
    JOURNAL OF IMMUNOLOGY, 2006, 176 (12): : 7456 - 7461